Kynetec: What’s Driving the Brazilian Biologicals Market

The 5th BioAgTech Congress was held April 22-26, 2024 in Raleigh, North Carolina and offered once again an opportunity for those in the biologicals sector to be at the cutting edge of insight, discussion and networking. Kynetec was platinum sponsor of the event.

Kynetec is a global leader in agriculture data and analytics. BioLogika, our unique dashboard, deep dives into biopesticides insights with data drawn from our network of over 200,000 growers worldwide.

André Dias, Executive Director LATAM at Kynetec, leads a team of 100 research professionals in Latin America, and his wide ranging and diverse experience in the agricultural sector made him a great choice to be one of the 30-plus BioAg Expert speakers at the event. His presentation took a deep dive into what is driving the growth of biologicals in Brazil, and highlights of the biologicals market for the latest soybean season.

Highlights included:

  • Biocontrol market value grows at a CAGR of 37% between 2018/9 and 2022/3.
  • Potential Area Treated (PAT) grows at a CAGR of 32% between 2018/9 and 2022/3.
    • Cultivated area increases.
    • Technology level increases for nematicides, fungicides and sucking insects.
  • Of the main biological organisms, André highlighted that:
    • Trichoderma is used on 18% of PAT.
    • Beauveria b. on 14% of PAT.
    • Bacillus amyloliquefaciens on 9% of PAT.
  • Across Brazil, 35% of growers have adopted biologicals, with higher levels of adoption in the Central West States.
  • 89% of the PAT for nematode control in soybean is treated with biologicals (2022/3).
  • Biologicals growth outpaces the chemical market by two-fold each year.
  • Growers are choosing biologicals for cost efficiency, with value capture prioritized over cost reduction.
  • The regulatory environment facilitates innovation, with biologicals registrations taking around 25% of the time of conventional molecules.

Top Articles
CropLife International President and CEO Emily Rees Appointed to B20 Co-Chair Role

Hide picture